These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10141252)

  • 1. A critical review of health-related economic evaluations in Australia: implications for health policy.
    Salkeld G; Davey P; Arnolda G
    Health Policy; 1995 Feb; 31(2):111-25. PubMed ID: 10141252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of economic evaluation in health care: Australian decision makers' perceptions.
    Ross J
    Health Policy; 1995 Feb; 31(2):103-10. PubMed ID: 10141251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.
    Lee KS; Brouwer WB; Lee SI; Koo HW
    Pharmacoeconomics; 2005; 23(7):709-21. PubMed ID: 15987227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of health care and policymaking.
    Johannesson M
    Health Policy; 1995 Sep; 33(3):179-90. PubMed ID: 10145120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalised cost-effectiveness analysis: an aid to decision making in health.
    Hutubessy RC; Baltussen RM; Torres-Edejer TT; Evans DB
    Appl Health Econ Health Policy; 2002; 1(2):89-95. PubMed ID: 14619255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of health technology: economic issues for health policy and policy issues for economic appraisal.
    Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1593-600. PubMed ID: 8047916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake.
    Merlo G; Page K; Ratcliffe J; Halton K; Graves N
    Appl Health Econ Health Policy; 2015 Jun; 13(3):303-9. PubMed ID: 25288052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A difficult balancing act: policy actors' perspectives on using economic evaluation to inform health-care coverage decisions under the Universal Health Insurance Coverage scheme in Thailand.
    Teerawattananon Y; Russell S
    Value Health; 2008 Mar; 11 Suppl 1():S52-60. PubMed ID: 18387068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can economic evaluation guidelines improve efficiency in resource allocation? The cases of Portugal, The Netherlands, Finland, and the United Kingdom.
    Kanavos P; Trueman P; Bosilevac A
    Int J Technol Assess Health Care; 2000; 16(4):1179-92. PubMed ID: 11155837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research into the use of health economics in decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'?
    Duthie T; Trueman P; Chancellor J; Diez L
    Health Policy; 1999 Jan; 46(2):143-57. PubMed ID: 10346286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health and economic evaluation in schizophrenia: implications for health policies.
    Moscarelli M
    Acta Psychiatr Scand Suppl; 1994; 382():84-8. PubMed ID: 8092004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resource allocation and economic evaluation in Australia's healthcare system.
    Baghbanian A; Hughes I; Khavarpour FA
    Aust Health Rev; 2011 Aug; 35(3):278-83. PubMed ID: 21871187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing healthcare budgets in times of austerity: the role of program budgeting and marginal analysis.
    Mitton C; Dionne F; Donaldson C
    Appl Health Econ Health Policy; 2014 Apr; 12(2):95-102. PubMed ID: 24458477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation and health care decision-making.
    Rutten F
    Health Policy; 1996 Jun; 36(3):215-29. PubMed ID: 10158267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tools of the trade: a comparative analysis of approaches to priority setting in healthcare.
    Mitton C; Donaldson C
    Health Serv Manage Res; 2003 May; 16(2):96-105. PubMed ID: 12803949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation in support of national health policy: the case of The Netherlands.
    Elsinga E; Rutten FF
    Soc Sci Med; 1997 Aug; 45(4):605-20. PubMed ID: 9226785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of patient preferences for comorbidities in cost-effectiveness analyses.
    Harris RA; Nease RF
    J Health Econ; 1997 Feb; 16(1):113-9. PubMed ID: 10167342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
    Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
    Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.